Biodesix Inc

Healthcare · Diagnostics & Research

29.10$ +5.0% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Biodesix Inc (BDSX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 95 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BDSX
Line item	Q4 17	Q1 18	Q2 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	–	–	–	–	–	–	45	–	45	47	121	115	102	90	76	62	75	63	93	81	78	87	99	87	116	103	97	86	88	89	87	95	95
Current Assets	–	–	–	–	5.9	–	13	13	5.3	18	18	86	81	68	56	44	27	35	24	53	35	25	29	40	28	58	44	39	30	32	33	33	41	44
Cash	–	–	–	–	-5.9	–	–	5.3	-5.3	12	6.3	62	55	56	48	33	16	24	15	43	25	17	20	26	11	42	31	26	18	21	17	19	26	30
Cash & Short-Term Investments	–	–	–	–	5.9	–	–	5.3	5.3	12	6.3	62	55	56	48	33	16	24	15	43	25	17	20	26	11	42	31	26	18	21	17	19	26	30
Receivables	–	–	–	–	–	–	5.3	5.3	2.9	2.9	5.4	15	18	5.3	2.8	3.7	3.8	5.5	4.4	5.1	4.9	4.1	5.8	7.7	9.9	10	8.0	8.6	7.6	7.5	13	9.0	9.5	9.2
Inventory	–	–	–	–	–	–	0.8	0.8	1.8	1.8	3.2	3.2	3.4	3.1	2.6	2.9	2.6	1.9	1.4	1.4	1.3	1.4	1.3	1.4	1.4	1.2	1.2	–	–	–	1.4	–	–	–
Property, Plant & Equipment	–	–	–	–	–	–	2.1	2.1	2.0	2.0	3.0	3.2	3.4	3.4	4.4	4.2	6.2	7.9	7.7	8.8	–	21	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	15	–	12	12	15	15	15	15	15	15	15	15	15	15	15	15	15	15	15	15	15	15	15	15	15	15	15
Intangible Assets	–	–	–	–	–	–	–	15	–	14	14	13	13	12	12	12	11	11	10	9.8	9.3	8.9	8.4	7.9	7.4	6.9	6.4	5.9	5.4	4.9	4.4	3.9	3.5	3.0
Total Liabilities	–	–	–	–	–	–	–	270	–	66	302	80	79	76	74	56	54	68	66	72	76	85	88	95	93	80	75	76	75	87	90	90	86	86
Current Liabilities	–	–	–	–	–	–	23	23	45	14	57	32	16	21	23	29	30	33	37	23	22	28	33	33	31	18	13	14	13	15	18	17	14	15
Short-Term Debt	–	–	–	–	–	–	–	12	–	4.1	34	12	2.7	3.1	0.0	0.0	1.2	13	16	1.6	1.8	1.6	1.2	0.3	0.3	0.3	0.7	0.7	1.1	1.2	1.4	1.4	1.5	1.6
Accounts Payable	–	–	–	–	–	–	1.7	1.7	0.9	0.9	3.5	9.0	3.7	1.2	1.6	1.7	2.1	1.8	2.1	1.7	1.6	3.5	2.9	2.9	3.2	2.2	2.5	2.2	2.9	3.0	3.6	3.1	3.7	2.2
Long-Term Debt	–	–	–	–	–	–	–	24	–	23	20	16	30	30	30	10.0	10	8.6	4.9	25	25	25	25	35	36	36	36	36	37	47	47	47	46	47
Shareholders' Equity	–	–	–	–	-14	–	–	-225	-31	-21	-255	41	36	26	16	20	7.8	7.7	-2.9	21	4.6	-7.0	-1.4	4.6	-5.5	36	28	21	11	1.1	-1.7	-2.5	9.1	9.1
Retained Earnings	–	–	–	–	–	–	-231	-227	-249	-251	-258	-259	-266	-277	-289	-302	-318	-333	-347	-367	-386	-399	-410	-420	-433	-444	-454	-462	-474	-485	-494	-498	-506	-513
Shares Outstanding	26	1.3	1.3	26	1.1	1.1	1.3	1.3	1.3	1.3	1.3	1.3	1.3	1.4	1.4	1.4	1.6	2.0	2.0	2.9	3.9	3.9	4.0	4.6	4.9	6.4	7.3	7.3	7.3	7.3	7.5	8.1	9.7	10

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings